Free Trial

Oscar Health (OSCR) Stock Forecast & Price Target

Oscar Health logo
$14.09 +0.59 (+4.37%)
(As of 12/20/2024 05:31 PM ET)

Oscar Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
2
Buy
5

Based on 9 Wall Street analysts who have issued ratings for Oscar Health in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 2 have given a sell rating, 2 have given a hold rating, 4 have given a buy rating, and 1 has given a strong buy rating for OSCR.

Consensus Price Target

$21.56
53.03% Upside
According to the 9 analysts' twelve-month price targets for Oscar Health, the average price target is $21.56. The highest price target for OSCR is $28.00, while the lowest price target for OSCR is $12.00. The average price target represents a forecasted upside of 53.03% from the current price of $14.09.
Get the Latest News and Ratings for OSCR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oscar Health and its competitors.

Sign Up

OSCR Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$21.56$22.93$24.17$7.70
Forecasted Upside53.03% Upside43.53% Upside8.23% Upside-16.12% Downside
Consensus Rating
Hold
Moderate Buy
Moderate Buy
Hold

OSCR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OSCR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Oscar Health Stock vs. The Competition

TypeOscar HealthFinance CompaniesS&P 500
Consensus Rating Score
2.44
2.50
2.51
Consensus RatingHoldHoldModerate Buy
Predicted Upside53.03% Upside18.66% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent OSCR News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/10/2024Jefferies Financial Group
2 of 5 stars
 Initiated CoverageUnderperform$12.00-27.56%
11/6/2024Bank of America
3 of 5 stars
 DowngradeNeutral ➝ Underperform$21.00 ➝ $13.50-26.35%
10/7/2024UBS Group
4 of 5 stars
 Initiated CoverageNeutral$23.00+14.20%
9/10/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$28.00 ➝ $28.00+60.73%
6/12/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$24.00 ➝ $27.00+34.90%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/30/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$28.00+38.75%
5/9/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$16.00 ➝ $21.00+1.20%
3/22/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$20.00+45.40%
8/30/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$5.00 ➝ $7.50+17.55%
8/9/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$7.00 ➝ $8.50+6.38%
2/14/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform$3.00 ➝ $6.00+13.42%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:11 AM ET.


OSCR Forecast - Frequently Asked Questions

According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for Oscar Health is $21.56, with a high forecast of $28.00 and a low forecast of $12.00.

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last year. There are currently 2 sell ratings, 2 hold ratings, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OSCR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSCR, but not buy additional shares or sell existing shares.

According to analysts, Oscar Health's stock has a predicted upside of 53.03% based on their 12-month stock forecasts.

Over the previous 90 days, Oscar Health's stock had 1 downgrade by analysts.

Oscar Health has been rated by research analysts at Bank of America, Jefferies Financial Group, and UBS Group in the past 90 days.

Analysts like Oscar Health less than other "finance" companies. The consensus rating score for Oscar Health is 2.44 while the average consensus rating score for "finance" companies is 2.50. Learn more on how OSCR compares to other companies.


This page (NYSE:OSCR) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners